Medica RCP |Precedex 200µg/2ml | Indications | Side Effects | Composition | Route | all.price

Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Precedex 200µg/2ml

Contraindicated

May be acceptable
Use with caution

Precedex 200µg/2ml :
Type	Medicine Authorised
Originator	B
Agent	Food & Drug Corporation
Distributor	Food & Drug Corporation
Laboratory	Hospira
Responsible Party	Hospira Inc
Origin	U.S.A.
Manufacturer	Hospira Inc
Origin	U.S.A.
ATC	N05CM18
Revision Date	01/01/2010

Precedex 200µg/2ml :

Injectable

Intravenous

Precedex 200µg/2ml :

N Nervous System

N05 Pycholeptiques

N05C Hypnotics and sedatives

N05CM Other hypnotics and sedatives

N05CM18 Dexmedetomidine

Precedex 200µg/2ml :

Dexmedetomidine : 200µg

Precedex 200µg/2ml :

Procedural Sedation 1 µg/kg over 10 minutes

Sedation of ventilated patients in ICU 1 µg/kg over 10 minutes

Precedex 200µg/2ml :

Not stated

* Excipient with known effect

Hazard Level
◼ Major
◼ Moderate
◼ Minor
◼ Safe

Precedex 200µg/2ml :

Revision Date : 20/11/2014

Frequency	Percentage
Very Common	≥ 1/10
Common	≥ 1/100 - < 1/10
Uncommon	≥ 1/1,000 - < 1/100
Rare	≥ 1/10,000 - < 1/1,000
Very Rare	< 1/10,000
Unknown	Cannot be Estimated

Effect	Frequency
Abdominal distension	Uncommon
Agitation	Common
Apnoea (Apnea)	Uncommon
Bradycardia	Very Common
Bradycardia neonatal	Not known
Cardiac arrest	Not known
Cardiac output decreased	Uncommon
Drug ineffective	Uncommon
Dry mouth (Xerostomia)	Common
Dyspnoea (dyspnea)	Uncommon
First degree atrioventricular block	Uncommon
Hallucination	Uncommon
Hyperglycaemia	Common
Hypertension	Very Common
Hyperthermia	Common
Hypoalbuminaemia	Uncommon
Hypoglycaemia	Common
Hypotension	Very Common
Metabolic acidosis	Uncommon
Myocardial infarction	Common
Myocardial ischaemia	Common
Nausea	Common
Respiratory depression	Common
Sinus arrest (Sinus pause)	Not known
Tachycardia	Common
Thirst	Uncommon
Vomiting	Common
Withdrawal syndrome	Common

Precedex 200µg/2ml :

Abu Dhabi

Bahrain

Egypt

Jordan

KSA

Kuweit

Lebanon

New Zealand

Oman

Turkey

UAE

Medicine Authorised

Dexmedetomidine Ever Pharma 200µg

P.P. : 10760952,95 LBP

( 5x2ml )

P/U: 2152190,59 LBP

Codipha

Ever Neuro Pharma

Medicine Authorised

Precedex 200µg/2ml

P.P. : 53550753,48 LBP

( 25x2ml )

P/U: 2142030,14 LBP

Food & Drug Corporation

Hospira

Medicine Authorised

Proxida 200µg/2ml

P.P. : 1781079,3 LBP

( 25x2ml )

P/U: 71243,17 LBP

Droguerie Mercury

Hikma Pharmaceuticals

▲ Most Expensive

▼ Least Expensive

P.P. =	Public Price
P/U =	Price Per Unit

- Products with same active ingredients

- Products with same strength

- Products with same route of administration

Medicine Authorised

Dexmedetomidine Ever Pharma 200µg

Codipha

Ever Neuro Pharma

Medicine Authorised

Dormifor 200mg

Raymond Georges Abou Adal

Arwan Laboratories

Medicine Authorised

Propofol 1% MCT/LCT Fresenius

Benta Trading Co

Fresenius Kabi

Medicine Authorised

Propofol-Lipuro 200mg

Droguerie de l'Union

B. Braun

Medicine Authorised

Provive

Macromed

Claris

Medicine Authorised

Proxida 200µg/2ml

Droguerie Mercury

Hikma Pharmaceuticals

Medicine Authorised

Recofol EDTA

Levant Alie Houses

Labatec Pharma

TAU

Safol

Hikma-Liban

Hikma Pharmaceuticals

NB : Products With Same Indication

Coming Very Soon

Different Units By MoH Code

Revision Date : 01/09/2010

Revision Date : 23/12/1999

Precedex 200µg/2ml MoH 3376 :

Form Solution for infusion

Packaging Vial (Type I Glass)

Package Size 25x2ml

Strength 200µg

Public Price 53550753,48 L.L.

Stratum E1

NSSF ✔

Quarantine ✘

Reg. Number 974233/01

Submission date 01/01/2001

Registration Year 2001

Price Comparison

You have to register to view this info

Note

You have to register to view this info

Note

Prices are provided in Dollar ($)

You have to register to view this info

Visitors Count: 30971257

Form	Solution for infusion
Packaging	Vial (Type I Glass)
Package Size	25x2ml
Strength	200µg
Public Price	53550753,48 L.L.
Stratum	E1
NSSF	✔
Quarantine	✘
Reg. Number	974233/01
Submission date	01/01/2001
Registration Year	2001